Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2225 of 3284 entries
View as:

Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT04199598 Org: User:
Start: 01/28/20 End: 04/03/20 Due: 04/03/21

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)

Phase: N/A Priority: Normal
NCT ID: NCT03979313 Org: User:
Start: 07/23/19 End: 03/21/23 Due: 03/21/24

An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01118325 Org: User:
Start: 04/30/10 End: 03/31/11 Due: 03/31/12

Faslodex in McCune-Albright Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00278915 Org: User:
Start: 01/31/06 End: 07/20/23 Due: 07/20/24

Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01572792 Org: User:
Start: 04/30/12 End: 06/30/13 Due: 06/30/14

Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics

Phase: N/A Priority: Normal
NCT ID: NCT01273363 Org: User:
Start: 12/31/10 End: 05/31/11 Due: 05/31/12

Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India

Phase: N/A Priority: Normal
NCT ID: NCT03471572 Org: User:
Start: 03/22/18 End: 12/21/18 Due: 12/21/19

Study to Assess Safety, Tolerability and Pharmacokinetics After Single Doses of AZD2516 to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00754715 Org: User:
Start: 09/30/08 End: 12/31/08 Due: 12/31/09

Tezepelumab Home Use Study

Phase: N/A Priority: Normal
NCT ID: NCT03968978 Org: User:
Start: 05/21/19 End: 06/05/20 Due: 06/05/21

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of Poly ADP-Ribose Polymerase-1 (PARP)

Phase: N/A Priority: Normal
NCT ID: NCT00516373 Org: User:
Start: 07/11/05 End: 04/26/23 Due: 04/26/24

Comparative Effectiveness of Symbicort vs. Spiriva Among COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01917643 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies

Phase: N/A Priority: Normal
NCT ID: NCT00805467 Org: User:
Start: 08/31/08 End: 08/31/13 Due: 08/31/14

A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)

Phase: N/A Priority: Normal
NCT ID: NCT03283267 Org: User:
Start: 10/24/17 End: 11/23/17 Due: 11/23/18

A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors

Phase: N/A Priority: Normal
NCT ID: NCT01551875 Org: User:
Start: 05/31/12 End: 07/31/13 Due: 07/31/14

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

Phase: N/A Priority: Normal
NCT ID: NCT05135455 Org: User:
Start: 04/21/22 End: 08/31/23 Due: 08/31/24

A Study of Ciclesonide Nasal Spray in Patients 18 Years and Older With Seasonal Allergic Rhinitis (BY9010/M1-413)

Phase: N/A Priority: Normal
NCT ID: NCT00384475 Org: User:
Start: 10/31/06 End: 01/31/07 Due: 01/31/08

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT03553563 Org: User:
Start: 07/24/18 End: 12/27/22 Due: 12/27/23

Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3

Phase: N/A Priority: Normal
NCT ID: NCT02322788 Org: User:
Start: 03/31/15 End: 11/30/15 Due: 11/30/16

Positron Emission Tomography (PET) Study With [11C]Raclopride to Determine Central D2 Dopamine Occupancy of SEROQUEL

Phase: N/A Priority: Normal
NCT ID: NCT00832221 Org: User:
Start: 01/31/09 End: 09/30/09 Due: 09/30/10

Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01652729 Org: User:
Start: 02/28/13 End: 04/30/14 Due: 04/30/15

Evaluate Efficacy and Safety in Japanese Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01294423 Org: User:
Start: 02/28/11 End: 03/31/12 Due: 03/31/13

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Phase: N/A Priority: Normal
NCT ID: NCT06147830 Org: User:
Start: 12/04/23 End: 11/29/24 Due: 11/29/25

Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

Phase: N/A Priority: Normal
NCT ID: NCT06324734 Org: User:
Start: 04/29/24 End: 07/15/24 Due: 07/15/25

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis

Phase: N/A Priority: Normal
NCT ID: NCT03401229 Org: User:
Start: 01/15/18 End: 07/31/20 Due: 07/31/21

A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04870112 Org: User:
Start: 06/28/21 End: 08/30/23 Due: 08/30/24